ImageneBio, Inc. Common Stock (IMA) is a publicly traded Healthcare sector company. As of July 7, 2026, IMA trades at $5.78 with a market cap of $65.76M and a P/E ratio of 0.00. IMA moved +0.00% today. Year to date, IMA is -15.61%; over the trailing twelve months it is flat. Its 52-week range spans $3.94 to $18.00. Analyst consensus is buy with an average price target of $13.00. Rallies surfaces IMA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for IMA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $5.78 |
| Market Cap | $65.76M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $18.00 |
| 52-Week Low | $3.94 |
| Volume | 8 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.32B |
| Net Income | $-255.32M |
| Gross Margin | 46.09% |
3 analysts cover IMA: 0 strong buy, 2 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $13.00.